Table 2.
Associations between FGF21 and various factors at baseline in all subjects.
| r | P | |
|---|---|---|
| Age | -0.252 | 0.121 |
| Weight | 0.032 | 0.848 |
| BMI | 0.088 | 0.596 |
| Waist circumference | 0.232 | 0.156 |
| FBG | 0.575 | <0.001∗∗ |
| 2 hPBG | 0.515 | 0.001∗∗ |
| FINS | 0.808 | <0.001∗∗ |
| HOMA-IR | 0.788 | <0.001∗∗ |
| HbA1c | 0.857 | <0.001∗∗ |
| TCH | 0.389 | 0.014∗ |
| HDL | -0.383 | 0.016∗ |
| LDL | 0.136 | 0.408 |
| TG | 0.286 | 0.078 |
| ALT | 0.649 | <0.001∗∗ |
| AST | 0.591 | <0.001∗∗ |
| ALP | 0.189 | 0.250 |
| GGT | 0.537 | <0.001∗∗ |
| Liver fat content | 0.717 | <0.001∗∗ |
Abbreviations: BMI: body mass index; FBG: fasting blood glucose; 2 hPBG: 2-hour postprandial blood glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; HbA1c: glycated hemoglobin; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; TG: triglyceride; LDL: low-density lipoprotein cholesterol; ALT: alanine amino transferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: γ-glutamyl transferase; FGF21: fibroblast growth factor 21. ∗P < 0.05; ∗∗P < 0.01.